Table 3. Patients’ compliance.
Treatment | Experimental group (N=103) |
Control group (N=103) |
P | |||
---|---|---|---|---|---|---|
n | % | n | % | |||
Radiotherapy | ||||||
Full dose (50 Gy) | 96 | 93.20 | 98 | 95.15 | 0.768 | |
≥90% planed dose | 102 | 99.03 | 103 | 100 | ||
Chemotherapy | ||||||
Capecitabine | ||||||
Full dose | 88 | 85.44 | 90 | 87.38 | 0.555 | |
≥90% planed dose | 97 | 94.17 | 98 | 95.15 | ||
≥80% planed dose | 100 | 97.09 | 100 | 97.09 | ||
Oxaliplatin | ||||||
Full dose | 84 | 81.55 | – | – | ||
≥75% planed dose | 91 | 88.35 | – | – | ||
≥50% planed dose | 102 | 99.03 | – | – |